Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ella Field

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 4, 2019
A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathyGabrielle Norrish, Tao Ding, Ella Field, et al.
European Journal of Preventive Cardiology|October 31, 2021
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathyGabrielle Norrish, Chen Qu, Ella Field, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2020
Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort StudyGabrielle Norrish, Henry Chubb, Ella Field, et al.
ESC Heart Failure|January 13, 2024
Natural history and outcomes in paediatric RASopathy-associated hypertrophic cardiomyopathyOlga Boleti, Gabrielle Norrish, Ella Field, et al.
International Journal of Cardiology|September 30, 2023
Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of eventsOlga D Boleti, Sotirios Roussos, Gabrielle Norrish, et al.
ESC Heart Failure|September 6, 2021
Clinical presentation and long-term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre studyGabrielle Norrish, Gali Kolt, Elena Cervi, et al.
JAMA Cardiology|August 15, 2019
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)Gabrielle Norrish, Tao Ding, Ella Field, et al.
European Journal of Preventive Cardiology|March 27, 2021
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathyGabrielle Norrish, Cristian Topriceanu, Chen Qu, et al.
Journal of the American College of Cardiology|July 11, 2020
Clinical Features and Natural History of PRKAG2 Variant Cardiac GlycogenosisAngela Lopez-Sainz, Fernando Dominguez, Luis Rocha Lopes, et al.
Journal of the American College of Cardiology|May 19, 2022
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic CardiomyopathyGabrielle Norrish, Aoife Cleary, Ella Field, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 4, 2019
A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathyGabrielle Norrish, Tao Ding, Ella Field, et al.
European Journal of Preventive Cardiology|October 31, 2021
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathyGabrielle Norrish, Chen Qu, Ella Field, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2020
Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort StudyGabrielle Norrish, Henry Chubb, Ella Field, et al.
ESC Heart Failure|January 13, 2024
Natural history and outcomes in paediatric RASopathy-associated hypertrophic cardiomyopathyOlga Boleti, Gabrielle Norrish, Ella Field, et al.
International Journal of Cardiology|September 30, 2023
Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of eventsOlga D Boleti, Sotirios Roussos, Gabrielle Norrish, et al.
ESC Heart Failure|September 6, 2021
Clinical presentation and long-term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre studyGabrielle Norrish, Gali Kolt, Elena Cervi, et al.
JAMA Cardiology|August 15, 2019
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)Gabrielle Norrish, Tao Ding, Ella Field, et al.
European Journal of Preventive Cardiology|March 27, 2021
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathyGabrielle Norrish, Cristian Topriceanu, Chen Qu, et al.
Journal of the American College of Cardiology|July 11, 2020
Clinical Features and Natural History of PRKAG2 Variant Cardiac GlycogenosisAngela Lopez-Sainz, Fernando Dominguez, Luis Rocha Lopes, et al.
Journal of the American College of Cardiology|May 19, 2022
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic CardiomyopathyGabrielle Norrish, Aoife Cleary, Ella Field, et al.
Pageof 5